Gene: SQSTM1
Official Full Name: sequestosome 1provided by HGNC
Gene Summary: This gene encodes a multifunctional protein that binds ubiquitin and regulates activation of the nuclear factor kappa-B (NF-kB) signaling pathway. The protein functions as a scaffolding/adaptor protein in concert with TNF receptor-associated factor 6 to mediate activation of NF-kB in response to upstream signals. Alternatively spliced transcript variants encoding either the same or different isoforms have been identified for this gene. Mutations in this gene result in sporadic and familial Paget disease of bone. [provided by RefSeq, Mar 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00195 | SQSTM1 gRNA3-gRNA4 KO plasmid | SQSTM1 | $850 | |||
GP00662 | SQSTM1 gRNA5-gRNA6 KO plasmid | SQSTM1 | $850 | |||
KO00401 | SQSTM1 Knockout cell line (HeLa) | Human | SQSTM1 | 1:3~1:6 | Negative | Online Inquiry |
KO00402 | SQSTM1 Knockout cell line (HCT 116) | Human | SQSTM1 | 1:2~1:4 | Negative | Online Inquiry |
KO00629 | SQSTM1 Knockout cell line (HEK293) | Human | SQSTM1 | 1:3~1:6 | Negative | Online Inquiry |
KO00830 | SQSTM1 Knockout cell line(Hep G2) | Human | SQSTM1 | 1:2~1:4 | Negative | Online Inquiry |
KO00835 | SQSTM1 Knockout cell line(BEAS-2B) | Human | SQSTM1 | 1:3~1:4 | Negative | Online Inquiry |
KO00964 | SQSTM1 Knockout cell line (HT-29) | Human | SQSTM1 | 1:2~1:4 | Negative | Online Inquiry |
KO13744 | SQSTM1 Knockout cell line (A549) | Human | SQSTM1 | 1:3~1:4 | Negative | Online Inquiry |
SQSTM1 Gene Knockout Cell Lines are specifically designed cellular models that have undergone targeted genetic modification to inactivate the SQSTM1 gene, which encodes the protein p62, a key regulator of various cellular processes including autophagy, oxidative stress response, and protein aggregation. By eliminating the expression of this gene, researchers can gain critical insights into its role in cellular homeostasis, signaling pathways, and its implications in diseases such as neurodegenerative disorders and cancer.
The key function of these knockout cell lines lies in their ability to mimic the physiological consequences of SQSTM1 gene depletion. This allows investigators to explore the modulation of autophagic processes and glycoprotein turnover without the influence of p62, thereby isolating its effects on cell function. The mechanism whereby the SQSTM1 gene contributes to cellular homeostasis involves the regulation of the NF-κB signaling pathway, as well as the selective degradation of ubiquitinated proteins, underscoring its role as a multifaceted adapter protein.
Scientifically, these cell lines are invaluable in the realm of research and clinical studies, providing a model for elucidating the molecular underpinnings of disorders that are associated with impaired autophagy and protein aggregation. They can serve as a platform for drug discovery and testing, enabling the development of therapeutics aimed at modulating autophagy pathways or targeting associated cellular dysfunctions. Compared to alternative models that may not fully replicate the loss of SQSTM1 function, these knockout cell lines provide a more precise tool for studying the pathophysiology of relevant diseases.
The unique selling points of the SQSTM1 Gene Knockout Cell Lines include their reliability, reproducibility, and the specificity of the knockout which eliminates confounding variables associated with off-target effects. This level of precision allows researchers and clinicians to draw more accurate conclusions from their experiments, ultimately leading to better applications of their findings in therapeutic contexts.
Choosing SQSTM1 Gene Knockout Cell Lines not only enhances the quality of experimental results but also empowers researchers with cutting-edge tools necessary to advance our understanding of complex biological systems. Our company prides itself on its extensive expertise in the development of innovative biological research products, ensuring that researchers have access to high-quality, validated models to support their scientific endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.